» Articles » PMID: 25317151

Give Progesterone a Chance

Overview
Date 2014 Oct 16
PMID 25317151
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

There is currently no standard pharmacological treatment for spinal cord injury. Here, we suggest that progesterone, a steroid hormone, may be a promising therapeutical candidate as it is already for traumatic brain injury, where it has reached phase II clinical trials. We rely on previous works showing anti-inflammatory, neuroprotective and promyelinating roles for progesterone after spinal cord injury and in our recent paper, in which we demonstrate that progesterone diminishes lesion, preserves white matter integrity and improves locomotor recovery in a clinically relevant model of spinal cord lesion.

Citing Articles

Hormonal Regulation of Oligodendrogenesis II: Implications for Myelin Repair.

Breton J, Long K, Barraza M, Perloff O, Kaufer D Biomolecules. 2021; 11(2).

PMID: 33669242 PMC: 7919830. DOI: 10.3390/biom11020290.


Progesterone through Progesterone Receptor B Isoform Promotes Rodent Embryonic Oligodendrogenesis.

Gonzalez-Orozco J, Del Moral-Morales A, Camacho-Arroyo I Cells. 2020; 9(4).

PMID: 32295179 PMC: 7226962. DOI: 10.3390/cells9040960.


Age and Sex-Related Changes to Gene Expression in the Mouse Spinal Cord.

McCallum-Loudeac J, Anderson G, Wilson M J Mol Neurosci. 2019; 69(3):419-432.

PMID: 31267314 DOI: 10.1007/s12031-019-01371-3.


Sex steroid hormones and brain function: PET imaging as a tool for research.

Moraga-Amaro R, van Waarde A, Doorduin J, de Vries E J Neuroendocrinol. 2017; 30(2).

PMID: 29237239 PMC: 5838537. DOI: 10.1111/jne.12565.


TRPV1 may increase the effectiveness of estrogen therapy on neuroprotection and neuroregeneration.

Ramirez-Barrantes R, Marchant I, Olivero P Neural Regen Res. 2016; 11(8):1204-7.

PMID: 27651755 PMC: 5020806. DOI: 10.4103/1673-5374.189162.


References
1.
Labombarda F, Gonzalez S, Lima A, Roig P, Guennoun R, Schumacher M . Effects of progesterone on oligodendrocyte progenitors, oligodendrocyte transcription factors, and myelin proteins following spinal cord injury. Glia. 2008; 57(8):884-97. DOI: 10.1002/glia.20814. View

2.
McConeghy K, Hatton J, Hughes L, Cook A . A review of neuroprotection pharmacology and therapies in patients with acute traumatic brain injury. CNS Drugs. 2012; 26(7):613-36. DOI: 10.2165/11634020-000000000-00000. View

3.
Schucht P, Raineteau O, Schwab M, Fouad K . Anatomical correlates of locomotor recovery following dorsal and ventral lesions of the rat spinal cord. Exp Neurol. 2002; 176(1):143-53. DOI: 10.1006/exnr.2002.7909. View

4.
Lammertse D . Clinical trials in spinal cord injury: lessons learned on the path to translation. The 2011 International Spinal Cord Society Sir Ludwig Guttmann Lecture. Spinal Cord. 2012; 51(1):2-9. DOI: 10.1038/sc.2012.137. View

5.
Hurlbert R . The role of steroids in acute spinal cord injury: an evidence-based analysis. Spine (Phila Pa 1976). 2002; 26(24 Suppl):S39-46. DOI: 10.1097/00007632-200112151-00009. View